Xylem stock holds steady as 2025 growth metrics frame 2026

Xylem Inc. stock (ISIN US98419M1009) is anchored today by its latest disclosed 2025 operating metrics, including revenue, margin, and cash flow trends that frame the company heading into 2026. The stock context also matters because Xylem trades on the NYSE under a widely followed large-cap industrial profile.

Revenue and margin set the tone

Xylem reported 2025 revenue of $8.6 billion, while adjusted EBITDA margin remained at 20.2% for the year. Those figures matter because they show the scale of the business and the profitability profile investors use to judge execution in water infrastructure and applied water technology.

The comparison is also concrete: revenue increased from the prior year, and the company continued to convert sales into double-digit operating profitability in 2025. That combination is the clearest financial anchor available for assessing Xylem stock without leaning on speculation.

Cash flow still counts

Free cash flow reached $1.0 billion in 2025, giving Xylem another dated measure of internal funding capacity. Net debt, capital spending, and acquisition discipline are the balance-sheet and cash topics that usually determine how much flexibility remains after a year of growth investment.

Xylem also reported full-year 2025 adjusted earnings per share of $4.17, a direct earnings marker that helps explain why the market continues to treat the shares as a quality industrial name. The number is useful because it ties revenue growth to bottom-line delivery in the same reporting period.

What the latest numbers say

The most important read-through from the 2025 set is that Xylem combined $8.6 billion of revenue with a 20.2% adjusted EBITDA margin and $1.0 billion of free cash flow. For investors, that trio is more informative than any short-term headline because it shows growth, profitability, and cash generation at the same time.

The quantified comparison is straightforward: the company ended 2025 with higher revenue than the previous year and maintained double-digit margin strength while producing $1.0 billion of free cash flow. That is the kind of pattern the market typically rewards in industrial technology, especially when water-related capital spending stays elevated.

Water infrastructure demand

Xylem's product set spans water transport, treatment, and analytics, so the company is tied to utility spending, industrial efficiency, and municipal infrastructure budgets. That exposure makes the business more cyclical than a pure software story, but also more directly levered to long-duration water investment themes.

In practice, the segment mix matters because treatment and measurement work can support recurring demand even when order timing shifts. The 2025 numbers suggest a business that is still balancing growth investment with cash discipline.

Trading context for Xylem stock

Xylem stock trades in the US market under a large-cap industrial valuation lens, so earnings quality and cash conversion remain more important than short-term narrative swings. The most recent dated metrics give a clearer anchor than opinion: $8.6 billion in revenue, 20.2% adjusted EBITDA margin, $1.0 billion in free cash flow, and $4.17 in adjusted EPS for 2025.

That mix leaves Xylem positioned as a water technology group where execution is still visible in the reported numbers rather than in promises. For market readers, the key issue is not the business model itself but whether those 2025 levels can be sustained into 2026.

Water treatment products

Xylem's portfolio includes pumps, treatment systems, metering, and analytics used across municipal and industrial water networks. Those categories matter because they connect the reported 2025 financial base to end markets that are large, regulated, and capital intensive.

NYSE quotation base

Xylem shares are listed in New York, and the company remains a US industrial with a global operating footprint. On the evidence available here, the clearest current anchors are the 2025 revenue, margin, cash flow, and EPS figures, which define the investment case more concretely than a single intraday quote would.